Trial Profile
An open label, randomized , crossover trial to assess the effect of food on Doravirine bioavailability administered as part of a fixed-dose combination with lamivudine and tenofovir disoproxil fumarate
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 06 Apr 2017
Price :
$35
*
At a glance
- Drugs Doravirine/lamivudine/tenofovir disoproxil fumarate (Primary)
- Indications HIV-1 infections
- Focus Pharmacokinetics
- 06 Apr 2017 New trial record
- 27 Mar 2017 Results assessing Doravirine bioavailability from this and other trial ( MK-1439-037) published in the Clinical Drug Investigation